CF Industries Total Revenue increased by 6.1% to $1.99B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 19.4%, from $1.66B to $1.99B. Over 4 years (FY 2021 to FY 2025), Total Revenue shows relatively stable performance with a 2.0% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates market expansion or higher demand, while a decrease may signal market saturation or competitive pressure.
Total revenue represents the gross inflow of economic benefits arising from the ordinary operating activities of the com...
Standard across all public companies; peers in the medical device and diagnostics sector typically show steady growth correlated with product adoption.
total_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.59B | $1.36B | $2.54B | $2.87B | $3.39B | $2.32B | $2.61B | $2.01B | $1.78B | $1.27B | $1.57B | $1.47B | $1.57B | $1.37B | $1.52B | $1.66B | $1.89B | $1.66B | $1.87B | $1.99B |
| QoQ Change | — | -14.2% | +86.5% | +12.9% | +18.2% | -31.5% | +12.4% | -22.9% | -11.8% | -28.3% | +23.4% | -6.4% | +6.9% | -12.8% | +11.2% | +9.1% | +13.7% | -12.2% | +12.8% | +6.1% |
| YoY Change | — | — | — | — | +113.4% | +70.4% | +2.7% | -29.8% | -47.6% | -45.2% | -39.8% | -26.9% | -11.4% | +7.6% | -3.0% | +13.1% | +20.2% | +21.1% | +22.8% | +19.4% |
| Segment | FY'22 | FY'23 | FY'24 | FY'25 |
|---|---|---|---|---|
| Cargo and Freight | $91.00M | $92.00M | $78.00M | $80.00M |
| Total | $11.19B | $6.63B | $5.94B | $7.08B |
All segment values are derived from annual filings.
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Ammonia | $409.00M | $353.00M | $572.00M | $520.00M | $491.00M | $457.00M | $708.00M | $627.00M |
| Granular Urea | $457.00M | $388.00M | $348.00M | $439.00M | $547.00M | $423.00M | $372.00M | $590.00M |
| UAN | $475.00M | $406.00M | $372.00M | $470.00M | $610.00M | $517.00M | $564.00M | $583.00M |
| Other | $133.00M | $117.00M | $131.00M | $133.00M | $125.00M | $140.00M | — | $128.00M |
| AN | $98.00M | $106.00M | $101.00M | $101.00M | $117.00M | $122.00M | $81.00M | $58.00M |
| Other Products | $133.00M | $117.00M | $131.00M | $133.00M | — | — | $147.00M | — |
| Total | $1.57B | $1.37B | $1.52B | $1.66B | $1.89B | $1.66B | $1.87B | $1.99B |
| Segment | FY'21 | FY'22 | FY'23 | FY'24 | FY'25 |
|---|---|---|---|---|---|
| Other foreign | $341.00M | $1.33B | $747.00M | $584.00M | $712.00M |
| North America excluding United States and Canada | $79.00M | $149.00M | $75.00M | $72.00M | $58.00M |
| Total | $6.54B | $11.19B | $6.63B | $5.94B | $7.08B |
All segment values are derived from annual filings.
| Segment | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| North America | $1.26B | $1.37B | $1.09B | $1.31B | $1.37B | $1.69B | $1.33B | $1.72B |
| Europe and Other | $210.00M | $206.00M | $285.00M | $210.00M | $290.00M | $204.00M | $331.00M | $262.00M |
| Total | $1.47B | $1.57B | $1.37B | $1.52B | $1.66B | $1.89B | $1.66B | $1.99B |